Challenges and solutions in the development of genomic biomarker panels: A systematic phased approach

K. Shahzad, A. Fatima, M. Cadeiras, N. Wisniewski, G. Bondar, R. Cheng, E. Reed, M. C. Deng

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

In the post-genome era, high throughput gene expression profiling has been successfully used to develop genomic biomarker panels (GBP) that can be integrated into clinical decision making. The development of GBPs in the context of personalized medicine is a scientifically challenging and resource-intense process. It needs to be accomplished in a systematic phased approach to address biological variation related to a clinical phenotype (e.g. disease etiology, gender, etc.) and minimize technical variation (noise). Here we present the methodological aspects of GBP development based on the experience of the Cardiac Allograft Rejection Gene Expression Observation (CARGO) study, a study that lead to the development of a molecular classifier for rejection screening in heart transplant patients.

Original languageEnglish (US)
Pages (from-to)334-341
Number of pages8
JournalCurrent Genomics
Volume13
Issue number4
DOIs
StatePublished - Jun 1 2012
Externally publishedYes

Fingerprint

Biomarkers
Precision Medicine
Gene Expression Profiling
Allografts
Noise
Observation
Genome
Transplants
Phenotype
Gene Expression
Clinical Decision-Making

Keywords

  • Gene expression transplantation
  • Genomics
  • Multiorgan dysfunction
  • Personalized medicine
  • Post-genome era

ASJC Scopus subject areas

  • Genetics
  • Genetics(clinical)

Cite this

Challenges and solutions in the development of genomic biomarker panels : A systematic phased approach. / Shahzad, K.; Fatima, A.; Cadeiras, M.; Wisniewski, N.; Bondar, G.; Cheng, R.; Reed, E.; Deng, M. C.

In: Current Genomics, Vol. 13, No. 4, 01.06.2012, p. 334-341.

Research output: Contribution to journalArticle

Shahzad, K, Fatima, A, Cadeiras, M, Wisniewski, N, Bondar, G, Cheng, R, Reed, E & Deng, MC 2012, 'Challenges and solutions in the development of genomic biomarker panels: A systematic phased approach', Current Genomics, vol. 13, no. 4, pp. 334-341. https://doi.org/10.2174/138920212800793339
Shahzad, K. ; Fatima, A. ; Cadeiras, M. ; Wisniewski, N. ; Bondar, G. ; Cheng, R. ; Reed, E. ; Deng, M. C. / Challenges and solutions in the development of genomic biomarker panels : A systematic phased approach. In: Current Genomics. 2012 ; Vol. 13, No. 4. pp. 334-341.
@article{a451c3256111493480c59dc1c16db2f5,
title = "Challenges and solutions in the development of genomic biomarker panels: A systematic phased approach",
abstract = "In the post-genome era, high throughput gene expression profiling has been successfully used to develop genomic biomarker panels (GBP) that can be integrated into clinical decision making. The development of GBPs in the context of personalized medicine is a scientifically challenging and resource-intense process. It needs to be accomplished in a systematic phased approach to address biological variation related to a clinical phenotype (e.g. disease etiology, gender, etc.) and minimize technical variation (noise). Here we present the methodological aspects of GBP development based on the experience of the Cardiac Allograft Rejection Gene Expression Observation (CARGO) study, a study that lead to the development of a molecular classifier for rejection screening in heart transplant patients.",
keywords = "Gene expression transplantation, Genomics, Multiorgan dysfunction, Personalized medicine, Post-genome era",
author = "K. Shahzad and A. Fatima and M. Cadeiras and N. Wisniewski and G. Bondar and R. Cheng and E. Reed and Deng, {M. C.}",
year = "2012",
month = "6",
day = "1",
doi = "10.2174/138920212800793339",
language = "English (US)",
volume = "13",
pages = "334--341",
journal = "Current Genomics",
issn = "1389-2029",
publisher = "Bentham Science Publishers B.V.",
number = "4",

}

TY - JOUR

T1 - Challenges and solutions in the development of genomic biomarker panels

T2 - A systematic phased approach

AU - Shahzad, K.

AU - Fatima, A.

AU - Cadeiras, M.

AU - Wisniewski, N.

AU - Bondar, G.

AU - Cheng, R.

AU - Reed, E.

AU - Deng, M. C.

PY - 2012/6/1

Y1 - 2012/6/1

N2 - In the post-genome era, high throughput gene expression profiling has been successfully used to develop genomic biomarker panels (GBP) that can be integrated into clinical decision making. The development of GBPs in the context of personalized medicine is a scientifically challenging and resource-intense process. It needs to be accomplished in a systematic phased approach to address biological variation related to a clinical phenotype (e.g. disease etiology, gender, etc.) and minimize technical variation (noise). Here we present the methodological aspects of GBP development based on the experience of the Cardiac Allograft Rejection Gene Expression Observation (CARGO) study, a study that lead to the development of a molecular classifier for rejection screening in heart transplant patients.

AB - In the post-genome era, high throughput gene expression profiling has been successfully used to develop genomic biomarker panels (GBP) that can be integrated into clinical decision making. The development of GBPs in the context of personalized medicine is a scientifically challenging and resource-intense process. It needs to be accomplished in a systematic phased approach to address biological variation related to a clinical phenotype (e.g. disease etiology, gender, etc.) and minimize technical variation (noise). Here we present the methodological aspects of GBP development based on the experience of the Cardiac Allograft Rejection Gene Expression Observation (CARGO) study, a study that lead to the development of a molecular classifier for rejection screening in heart transplant patients.

KW - Gene expression transplantation

KW - Genomics

KW - Multiorgan dysfunction

KW - Personalized medicine

KW - Post-genome era

UR - http://www.scopus.com/inward/record.url?scp=84862627907&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84862627907&partnerID=8YFLogxK

U2 - 10.2174/138920212800793339

DO - 10.2174/138920212800793339

M3 - Article

C2 - 23204923

AN - SCOPUS:84862627907

VL - 13

SP - 334

EP - 341

JO - Current Genomics

JF - Current Genomics

SN - 1389-2029

IS - 4

ER -